The review will take upto 210 calendar days. TIS as stated are ahead of the game with preparation that was made if such a case occurred.
My read of the the the release is that we are on a goer. TIS will open up sales to many other countries as a result of EU approval.
No doubt there will be downrampers trying to get hold of this stock but for myself as a longterm holder, the wait ahead is nowhere near the doom and gloom that I expect some to post on these threads.
Exciting times ahead and I personally consider that TIS shares are one of the best shares I hold for future earning potential.
We have a maximum of 210 calendar days but I anticipate that it will be shorter IMO.
Good luck to all longterm holders.
- Forums
- ASX - By Stock
- TIS
- change in medical device classication?
change in medical device classication?, page-3
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)